Opinion: Drug pricing and the ‘impossible trinity’ for patients
New seven-figure gene therapies show that neither insurers nor patients can win on drug pricing.
You don’t have to be an economist to understand the law of demand: The higher the price, the less likely a customer is to buy a product. This, of course, limits how much companies can charge.
The law of demand applies to pharmaceuticals, but with one big difference. It’s not always the customer who decides that the price is too high. Often, it’s the insurer.
What's Your Reaction?
